Dova Pharmaceuticals

Quote
anonymous said:
Impossible goal from desperate management. Clearly pressure is huge now at all levels because they have to deliver after buying this dog for $1.7B and sales have been dropping for months. Things are going to get very very ugly, smart that you're getting out, me too!
Click to expand...

That dude Dave Querry lied to management along with all of his other buddies; they all knew this thing could never get to 500$m. But mgt fell for it. That marketing guy MM is a stupid fcuk
 






anonymous said:
That dude Dave Querry lied to management along with all of his other buddies; they all knew this thing could never get to 500$m. But mgt fell for it. That marketing guy MM is a stupid fcuk
Click to expand...

And the charade continues today! Marketing makes shit up about the disease and produces the worst sales lit possible. That said, I'm happy about their incompetence which will hasten the decline of Sobi.
 












anonymous said:
Fong and Adam knew they where misleading them. They put on the best possible case
Click to expand...

Karen, sounds like you're part of Sobi mgmt and realize you were taken to the cleaners by a CTI mgmt team that was 10x smarter than you! Salesmanship requires the ability to persuade that the most optimal outcome is attainable. That or as PT Barum said, "There is a fool born every minute," and "Guido got snookered!"
 


















anonymous said:
Sobi mgmt saved some coin in September when they laid off legacy Sobi reps who had an LTI payment coming in Feb. If Vonjo is indeed the focus for 2024 mgmt should lay off any reps due a Feb LTI payment who were less than 100% to plan on Vonjo in Q4 (there was a # in Tableau) and are tracking less than 100% to plan in Q1.
Click to expand...

Agreed. Everyone knows that doptelet days are numbered, Teva has ANDA first-filer 6 months of exclusivity but this expires in a few months and the price will tank. Community sales will soon become non-profitable and many cams and managers will be laid off. If you aren't at goal for vonjo and don't call on major institutions, best to get out while you can.
 












So Vonjo only hit $30m in sales. Sad. This product is going to have a hard time peaking at 150M USD. They really f this one up. Never will see their dollars back on this one. Worst deal ever
 






anonymous said:
So Vonjo only hit $30m in sales. Sad. This product is going to have a hard time peaking at 150M USD. They really f this one up. Never will see their dollars back on this one. Worst deal ever
Click to expand...

Shouldn't surprise anyone that Hank and Ren are complete idiots when it comes to driving sales of a consultative therapy like Vonjo. Love the fact that they believe a simplified messaging scheme -- while more attuned to the ability of their primary care skill set Legacy Sobi sales team will inevitably lead to continued market share erosion vs rux and mome. If those morons cut headcount now they could save money on the Maryland POA. Keep cutting CTI reps -- that has been very helpful to driving Vonjo sales!
 






anonymous said:
So Vonjo only hit $30m in sales. Sad. This product is going to have a hard time peaking at 150M USD. They really f this one up. Never will see their dollars back on this one. Worst deal ever
Click to expand...

Yes it sad. However, Vonjo Tableau presents a hilarious picture of month over month decline in Vonjo bottle count since the September layoff.
 






Word is that they are going to work on getting a new Vonjo marketing team or at least the lead. The lead now is not well liked and is causing lot's of issues. Doesn't really matter TBH Sub $100m this year
 






anonymous said:
Shouldn't surprise anyone that Hank and Ren are complete idiots when it comes to driving sales of a consultative therapy like Vonjo. Love the fact that they believe a simplified messaging scheme -- while more attuned to the ability of their primary care skill set Legacy Sobi sales team will inevitably lead to continued market share erosion vs rux and mome. If those morons cut headcount now they could save money on the Maryland POA. Keep cutting CTI reps -- that has been very helpful to driving Vonjo sales!
Click to expand...
 






Makes no sense to drive CTI reps away but they are going to leave anyway. In talking to a few they were concerned that they would never be able to hit the numbers set by Cti mgt They made a few bucks and they can go on to something else that gets them more $
 






Sobi Loser Mgmt team is getting what it deserves. They increased Sobi rep pay $20K overnight on 9/8 and then told the CTI reps you'll get your $10k 7 months from now. F Sobi! Here's hoping GSK and Teva destroy them!
 












Duh said:
Consultative sale at that one drive buy office lunch a year? GTFOH.

CTI reps are the very best at consulting with Linkedin and thats about it.
Click to expand...

The poor Vonjo sales results speak volumes! Month over month declines in the national average bottles per rep each and every month since August! CTI drove the business and Sobi reps are incapable of doing the same. Sobi mgmt recognized that they needed to dumb down the Vonjo message for their dummy legacy sales force and hence the new approach.
 






anonymous said:
The poor Vonjo sales results speak volumes! Month over month declines in the national average bottles per rep each and every month since August! CTI drove the business and Sobi reps are incapable of doing the same. Sobi mgmt recognized that they needed to dumb down the Vonjo message for their dummy legacy sales force and hence the new approach.
Click to expand...
 






so there is now way to grow this company. They spent 1.7b on Vonjo; they will never see their money back on that. The board is not going to approve another Acquistion. They won't be able to raise any money.

Has anybody heard about the Vonjo patent? That thing may expire 2027/28. They applied for an extension but no one has heard the status? Or have they?
 






anonymous said:
Agreed. Everyone knows that doptelet days are numbered, Teva has ANDA first-filer 6 months of exclusivity but this expires in a few months and the price will tank. Community sales will soon become non-profitable and many cams and managers will be laid off. If you aren't at goal for vonjo and don't call on major institutions, best to get out while you can.
Click to expand...

Agree 100%. Teva got the eltrombopag approval in November and they just ignored this, so typical! CEO on the town hall sounded like he's ready to fire a lot people over this mess which he caused!
 






Top Bottom
Back
Quote